Masimo Revenue 2010-2024 | MASI

Masimo annual/quarterly revenue history and growth rate from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Masimo revenue for the quarter ending June 30, 2024 was $0.496B, a 9.01% increase year-over-year.
  • Masimo revenue for the twelve months ending June 30, 2024 was $2.017B, a 7.76% decline year-over-year.
  • Masimo annual revenue for 2023 was $2.048B, a 0.6% increase from 2022.
  • Masimo annual revenue for 2022 was $2.036B, a 64.28% increase from 2021.
  • Masimo annual revenue for 2021 was $1.239B, a 8.35% increase from 2020.
Masimo Annual Revenue
(Millions of US $)
2023 $2,048
2022 $2,036
2021 $1,239
2020 $1,144
2019 $938
2018 $858
2017 $790
2016 $713
2015 $630
2014 $587
2013 $547
2012 $493
2011 $439
2010 $405
2009 $349
Masimo Quarterly Revenue
(Millions of US $)
2024-06-30 $496
2024-03-31 $493
2023-12-31 $549
2023-09-30 $479
2023-06-30 $455
2023-03-31 $565
2022-12-31 $617
2022-09-30 $549
2022-06-30 $565
2022-03-31 $304
2021-12-31 $328
2021-09-30 $307
2021-06-30 $305
2021-03-31 $299
2020-12-31 $295
2020-09-30 $278
2020-06-30 $301
2020-03-31 $270
2019-12-31 $248
2019-09-30 $229
2019-06-30 $230
2019-03-31 $232
2018-12-31 $223
2018-09-30 $211
2018-06-30 $212
2018-03-31 $213
2017-12-31 $208
2017-09-30 $193
2017-06-30 $192
2017-03-31 $197
2016-12-31 $201
2016-09-30 $168
2016-06-30 $173
2016-03-31 $171
2015-12-31 $167
2015-09-30 $153
2015-06-30 $156
2015-03-31 $155
2014-12-31 $162
2014-09-30 $144
2014-06-30 $141
2014-03-31 $140
2013-12-31 $142
2013-09-30 $131
2013-06-30 $137
2013-03-31 $136
2012-12-31 $132
2012-09-30 $119
2012-06-30 $123
2012-03-31 $119
2011-12-31 $112
2011-09-30 $104
2011-06-30 $110
2011-03-31 $113
2010-12-31 $106
2010-09-30 $101
2010-06-30 $100
2010-03-31 $99
2009-12-31 $93
2009-09-30 $87
2009-06-30 $84
2009-03-31 $85
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $7.385B $2.048B
Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $228.667B 27.41
Intuitive Surgical (ISRG) United States $171.263B 96.97
Alcon (ALC) Switzerland $47.978B 33.77
IQVIA Holdings (IQV) United States $41.900B 23.74
Edwards Lifesciences (EW) United States $39.451B 25.29
IDEXX Laboratories (IDXX) United States $39.315B 47.29
DexCom (DXCM) United States $27.294B 38.92
STERIS (STE) Ireland $22.783B 26.58
SONOVA HOLDING (SONVY) Switzerland $21.950B 0.00
Waters (WAT) United States $20.926B 31.20
Hologic (HOLX) United States $18.638B 20.26
Sysmex ADR (SSMXY) Japan $12.525B 39.28
Fresenius Medical Care AG KGaA (FMS) Germany $12.147B 13.62
Teleflex (TFX) United States $11.269B 17.52
Globus Medical (GMED) United States $9.568B 26.77
Penumbra (PEN) United States $7.564B 78.52
Glaukos (GKOS) United States $7.197B 0.00
TransMedics (TMDX) United States $4.636B 198.53
Integer Holdings (ITGR) United States $4.329B 25.32
PROCEPT BioRobotics (PRCT) United States $3.773B 0.00
LivaNova (LIVN) United Kingdom $2.923B 17.14
Tandem Diabetes Care (TNDM) United States $2.735B 0.00
Nihon Kohden (NHNKY) Japan $2.599B 16.17
Elekta AB (EKTAY) Sweden $2.596B 21.15
Veracyte (VCYT) United States $2.523B 156.38
Inari Medical (NARI) United States $2.443B 0.00
RxSight (RXST) United States $1.809B 0.00
Integra LifeSciences Holdings (IART) United States $1.319B 6.01
Artivion (AORT) United States $1.108B 101.69
AVANOS MEDICAL, INC (AVNS) United States $1.066B 19.02
OPKO Health (OPK) United States $1.039B 0.00
Pulse Biosciences (PLSE) United States $0.979B 0.00
Alphatec Holdings (ATEC) United States $0.771B 0.00
Mesa Laboratories (MLAB) United States $0.723B 18.25
IRadimed (IRMD) United States $0.631B 34.12
OrthoPediatrics (KIDS) United States $0.628B 0.00
SiBone (SIBN) United States $0.612B 0.00
AxoGen (AXGN) United States $0.599B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.584B 0.00
Paragon 28 (FNA) United States $0.491B 0.00
Pacific Biosciences Of California (PACB) United States $0.469B 0.00
Tactile Systems Technology (TCMD) United States $0.343B 10.47
Treace Medical Concepts (TMCI) United States $0.332B 0.00
ClearPoint Neuro (CLPT) United States $0.309B 0.00
Sight Sciences (SGHT) United States $0.292B 0.00
AngioDynamics (ANGO) United States $0.248B 0.00
Delcath Systems (DCTH) United States $0.244B 0.00
Inogen (INGN) United States $0.216B 0.00
NeuroPace (NPCE) United States $0.199B 0.00
Accuray (ARAY) United States $0.192B 0.00
CVRx (CVRX) United States $0.191B 0.00
Nevro (NVRO) United States $0.185B 0.00
Atossa Genetics (ATOS) United States $0.185B 0.00
Semler Scientific (SMLR) United States $0.175B 12.25
Alpha Tau Medical (DRTS) Israel $0.159B 0.00
908 Devices (MASS) United States $0.121B 0.00
KORU Medical Systems (KRMD) United States $0.120B 0.00
Spectral Diagnostics (EDTXF) Canada $0.119B 0.00
Sensus Healthcare (SRTS) United States $0.103B 15.34
EDAP TMS S.A (EDAP) France $0.098B 0.00
Monogram Orthopaedics (MGRM) United States $0.074B 0.00
Hyperfine (HYPR) United States $0.072B 0.00
WORK Medical Technology Group (WOK) China $0.068B 0.00
InspireMD (NSPR) Israel $0.066B 0.00
Envoy Medical (COCH) United States $0.065B 0.00
Covalon Technologies (CVALF) Canada $0.063B 0.00
LENSAR (LNSR) United States $0.052B 0.00
Accelerate Diagnostics (AXDX) United States $0.046B 0.00
Lucid Diagnostics (LUCD) United States $0.044B 0.00
EnVVeno Medical (NVNO) United States $0.043B 0.00
Adagio Medical Holdings (ADGM) United States $0.039B 0.00
Rapid Micro Biosystems (RPID) United States $0.039B 0.00
DarioHealth (DRIO) United States $0.034B 0.00
Vicarious Surgical (RBOT) United States $0.034B 0.00
T2 Biosystems (TTOO) United States $0.032B 0.00
Precision Optics (POCI) United States $0.030B 0.00
Pixie Dust Technologies (PXDT) Japan $0.028B 0.00
Neuronetics (STIM) United States $0.026B 0.00
Ekso Bionics Holdings (EKSO) United States $0.019B 0.00
Spectral AI (MDAI) United States $0.018B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.017B 0.00
NexGel (NXGL) United States $0.016B 0.00
Microbot Medical (MBOT) United States $0.015B 0.00
Autonomix Medical (AMIX) United States $0.014B 0.00
QT Imaging Holdings (QTI) United States $0.013B 0.00
PAVmed (PAVM) United States $0.013B 0.00
Aspira Women's Health (AWH) United States $0.013B 0.00
Check-Cap (CHEK) Israel $0.008B 0.00
ENDRA Life Sciences (NDRA) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Nuwellis (NUWE) United States $0.002B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00